APTINYX
Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. This mechanism has applicability across a number of CNS disorders. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need.
APTINYX
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Evanston, Illinois, United States
Country:
United States
Website Url:
http://www.aptinyx.com
Total Employee:
11+
Status:
Active
Contact:
(847)871-0377
Total Funding:
273.9 M USD
Technology used in webpage:
Content Delivery Network Amazon HSTS IPv6 Cloudflare Hosting Pound Sterling Cloudflare CDN ReCAPTCHA V2 Japanese Yen ASP.NET Ajax
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Mereo Biopharma
Mereo is a new UK-based speciality biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Aptinyx
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Aptinyx
Savitr Capital
Savitr Capital investment in Post-IPO Equity - Aptinyx
Longitude Capital
Longitude Capital investment in Series B - Aptinyx
Beecken Petty O'Keefe & Company
Beecken Petty O'Keefe & Company investment in Series B - Aptinyx
HBM Healthcare Investments
HBM Healthcare Investments investment in Series B - Aptinyx
Adams Street Partners
Adams Street Partners investment in Series B - Aptinyx
Genesys Capital
Genesys Capital investment in Series B - Aptinyx
Adage Capital Management
Adage Capital Management investment in Series B - Aptinyx
Agent Capital
Agent Capital investment in Series B - Aptinyx
Official Site Inspections
http://www.aptinyx.com Semrush global rank: 9.11 M Semrush visits lastest month: 445
- Host name: 172.67.200.24
- IP address: 172.67.200.24
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aptinyx"
Aptinyx - Crunchbase Company Profile & Funding
Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous …See details»
About Aptinyx - Aptinyx
Aptinyx Inc. is a clinical-stage biopharmaceutical company discovering and developing transformative therapies for challenging disorders of the brain and nervous system. Aptinyx …See details»
Biotech startup Aptinyx plans to shut down - Crain's …
May 8, 2023 All Aptinyx board members resigned May 4, and CEO Andy Kidd, Chief Financial Officer Ashish Khanna and Executive Chairman Norbert Riedel stepped down, according to the filing.See details»
Aptinyx 2025 Company Profile: Valuation, Funding
Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic …See details»
Aptinyx - Funding, Financials, Valuation & Investors - Crunchbase
Aptinyx is registered under the ticker NASDAQ:APTX . Their stock opened with $16.00 in its Jun 25, 2018 IPO. Aptinyx is funded by 22 investors. National Institutes of Health and K2 …See details»
APTINYX: Shareholders Board Members Managers and Company …
Aptinyx, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of proprietary, synthetic small molecules for …See details»
Aptinyx Inc. - AnnualReports.com
Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders.See details»
Aptinyx - Org Chart, Teams, Culture & Jobs - The Org
Aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system, starting with painful diabetic …See details»
Aptinyx Company Profile - Office Locations, Competitors ... - Craft
Jul 18, 2024 Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders. The …See details»
Investor Contacts - Aptinyx
To request information, please fill out and submit the form below, or contact us at: [email protected] 847-871-0377See details»
Aptinyx Inc. Company Profile | Evanston, IL - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aptinyx Inc. of Evanston, IL. Get the latest business insights from Dun & Bradstreet.See details»
Aptinyx Company Profile | Management and Employees List
Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Aptinyx's email format. Company Overview. Team Members. Technologies. Email Formats. Competitors. …See details»
Aptinyx - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Aptinyx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Member and Advisor Profiles 9. Contacts 33. About. …See details»
APTINYX INC CORPORATE GOVERNANCE GUIDELINES
Business, government, non-profit or academic organization of high standing. • The nominee shall be highly accomplished in his or her respective field, with superior credentials and recognition. …See details»
Aptinyx - Bain Capital Life Sciences
Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and …See details»
Aptinyx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Feb 2, 2025 Aptinyx Inc. is a biopharmaceutical company. Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AISee details»
Aptinyx dumps dementia drug, stops PTSD trial after phase 2 flop
Feb 28, 2023 Last year, the third midphase failure of NYX-2925 prompted Aptinyx to drop the pain program and switch its attention to a pair of other NMDA receptor positive allosteric …See details»
Preclinical Data from Aptinyx’s NMDA Receptor Modulators to be ...
Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today …See details»
Aptinyx Reports Fourth Quarter and Full Year 2021 Results and ...
Mar 23, 2022 APTINYX INC. CONDENSED STATEMENTS OF OPERATIONS (in thousands, except per share data) (Unaudited) Three Months Ended December 31, Year Ended …See details»
Our Approach - Aptinyx
Aptinyx has a platform for discovery of novel compounds that work through a unique mechanism to modulate—rather than block or over-activate—NMDA receptors and enhance synaptic …See details»